In this article, we will discuss Acalabrutinib (Dosage Overview). So, let’s get started.
Acalabrutinib is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.
The recommended dose of acalabrutinib is 100 mg taken orally approximately every twelve hours until disease progression or unacceptable toxicity.
Advise patients to swallow capsule whole with water. Advise patients not to open, break or chew the capsules. Acalabrutinib may be taken with or without food. If a dose of Acalabrutinib is missed by more than 3 hours, it should be skipped and the next dose should be taken at its regularly scheduled time.
Extra capsules of Acalabrutinib should not be taken to make up for a missed dose.